4.8 Article

Primitive hematopoietic ceHs resist HIV-1 infection via p21Waf1/Cip1/Sdi1

期刊

JOURNAL OF CLINICAL INVESTIGATION
卷 117, 期 2, 页码 473-481

出版社

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI28971

关键词

-

资金

  1. NHLBI NIH HHS [R01 HL71859, R01 HL071859, R01 HL044851] Funding Source: Medline
  2. NIAID NIH HHS [K18 AI055313, K18 AI55313] Funding Source: Medline

向作者/读者索取更多资源

Hematopoietic stem cells are resistant to HIV-1 infection. Here, we report a novel mechanism by which the cyclin-dependent kinase inhibitor (CKI) p21(Waf1)/(Cip1)/(Sdi1) (p21), a known regulator of stem cell pool size, restricts HIV-1 infection of primitive hematopoietic cells. Modifying p21 expression altered HIV-1 infection prior to changes in cell cycling and was selective for p21 since silencing the related CKIs, p27(Kip1) and p18(INK4C), had no effect on HIV-1. We show that p21 blocked viral infection by complexing with HIV-1 integrase and aborting chromosomal integration. A closely related lentivirus with a distinct integrase, SlVmac-251, and the other cell-intrinsic inhibitors of HIV-1, Trim5 alpha, PML, Murr1, and IFN-alpha, were unaffected by p21. Therefore, p21 is an endogenous cellular component in stem cells that provides a unique molecular barrier to HIV-1 infection and may explain how these cells remain an uninfected sanctuary in HIV disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据